LAVA Therapeutics
LVTX
LVTX
20 hedge funds and large institutions have $12.5M invested in LAVA Therapeutics in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
50% less call options, than puts
Call options by funds: $102K | Put options by funds: $203K
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
20
Holding in Top 10
–
Calls
$102K
Puts
$203K
Top Buyers
| 1 | +$1.22M | |
| 2 | +$515K | |
| 3 | +$273K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$60.9K |
| 5 |
Two Sigma Advisers
New York
|
+$55.6K |
Top Sellers
| 1 | -$2.97M | |
| 2 | -$1.33M | |
| 3 | -$131K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$34.1K |
| 5 |
Millennium Management
New York
|
-$26.8K |